UCLA Campus    |   UCLA Health    |   School of Medicine Translate:
UCLA Health It Begins With U

Vital Signs


Vital Signs

Summer 2009

New Tool Delivers Higher Doses of Radiation in Less Time

UCLA Department of Radiation Oncology: New tool delivers higher doses of radiation in less timeThe UCLA Department of Radiation Oncology is the first center in the Los Angeles area to install a new, state-of-the-art, image-guided device that provides more accurate, concentrated doses of radiation, allowing patients to be treated in fewer visits with fewer side effects.

The Novalis TX has three imaging modalities to track the location of tumors during breathing and other movement, allowing physicians to pinpoint the location of the cancerous tissue and position patients so that radiation is delivered with the highest precision. The device also continuously shapes the radiation beam to mirror the tumor’s size and dimensions as it rotates around the patient, delivering treatment from different angles.

“In some cases, the period needed for radiation can be reduced from six weeks of daily treatments to just three to five days because of the high doses that can be delivered using the SBRT approach,” says Percy Lee, M.D., director of the UCLA Stereotactic Body Radiation Therapy (SBRT) Program and a researcher at UCLA’s Jonsson Comprehensive Cancer Center.

“It allows us to shape the dose and target tumors very precisely to protect normal tissues,” says UCLA radiation oncologist Michael Selch, M.D. The device “will open up new avenues of radiosurgery for us, allowing us to treat even difficult-to-plan tumors with unusual shapes.”

To watch a video about the Novalis TX, go to:


Add a comment

Please note that we are unable to respond to medical questions through the comments feature below. For information about health care, or if you need help in choosing a UCLA physician, please contact UCLA Physician Referral Service (PRS) at 1-800-UCLA-MD1 (1-800-825-2631) and ask to speak with a referral nurse. Thank you!

comments powered by Disqus